Abstract
Two recent studies on a rare androgen-dependent form of breast cancer have shed light on the biology of luminal tumours and reinforced the view that interfering with androgen signalling may have a place in the therapy of some forms of breast cancer.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Apocrine Glands / metabolism
-
Apocrine Glands / pathology
-
Breast Neoplasms / genetics
-
Breast Neoplasms / metabolism*
-
Female
-
Humans
-
Receptors, Androgen / genetics
-
Receptors, Androgen / metabolism*
-
Receptors, Estrogen / genetics
-
Receptors, Estrogen / metabolism*
-
Signal Transduction
Substances
-
Receptors, Androgen
-
Receptors, Estrogen